 |
|
| LEGISLATIVE |
| Senate
Recognizes September 2009 as AFib Awareness Month
House Panel Holds Hearing on Isotope
Production Act
Sen. Baucus Introduces Health Reform
Proposal |
| REGULATORY |
| FDA,
Device Updates |
| QUALITY |
| Coverage
Available Online for ACC’s 2009 Legislative Conference |
| LEGISLATIVE |
Senate
Recognizes September 2009 as AFib Awareness Month
The
Senate recently unanimously adopted a resolution (S.Res
262) designating September 2009 as “National Atrial
Fibrillation Awareness Month.” The resolution is intended
to support efforts to educate people about atrial fibrillation
and recognize the need for additional research into potential
treatments.
|
|
House
Panel Holds Hearing on Isotope Production Act
The
House Energy and Commerce Subcommittee on the Environment
on Sept. 9 held a hearing on the “American Medical Isotopes
Production Act of 2009" (H.R. 3276). This bill would
authorize $163 million over five years to start domestic production
of molybdenum-99 (Mo-99) as soon as possible. Under the bill,
the funds would be used to support private sector or research
sector projects to establish domestic Mo-99 production. Witnesses
included Parrish Staples of the National Nuclear Security
Administration, Steven Larson of Memorial Sloan-Kettering
Cancer Center and Michael Duggy of Lantheus Medical Imaging
In May,
the Canadian reactor that usually supplies 60 percent of U.S.
demand broke down and a major reactor in the Netherlands will
shut down for necessary maintenance later this month. The
Netherlands shutdown will leave the total global production
capacity at approximately 10 percent of normal levels for
one month. The ACC and other cardiovascular specialty societies
endorse the legislation. More information about the shortages
is available on the American
Society of Nuclear Cardiology’s Web site. |
|
Sen.
Baucus Introduces Health Reform Proposal
Senate
Finance Committee Chair Max Baucus (D-Mont.) today introduced
"America's Health Future Act," a health reform proposal
that would cost $856 billion over 10 years. The plan would
require all individuals to purchase health insurance or pay
a fine, with lower income individuals receiving subsidies
to help afford the coverage. It also would bar insurance companies
from certain practices such as denial for pre-existing conditions,
coverage rescissions or annual caps or lifetime limits on
coverage. In addition, the proposal would create a national
insurance exchange for individuals and small businesses to
purchase insurance. The plan does not include a public option
but rather would create a network of not-for-profit health
insurance cooperatives. Related to cardiology, the plan would:
- Replace
the scheduled 21 percent Medicare physician payment cut
with a 0.5 percent increase for 2010
- Require
more timely feedback from the Physician Quality Reporting
Initiative (PQRI)
Establish a PQRI appeals process and create a maintenance
of certification participation option
- Encourage
states to test medical liability reform options
- Create
a Centers for Medicare and Medicaid Services' Innovation
Center to test new Medicare payment structures, and
- Develop
and evaluate bundling plan options to coordinate patient
care.
Senate
Majority Leader Harry Reid (D-Nev.) has said he will bring
together a group of Senate Democrats on Thursday to discuss
the proposal. Sen. Baucus said the Finance Committee intends
to take up the bill Sept. 22. For the summary visit: http://finance.senate.gov/press/Bpress/2009press/prb091609.pdf.
The
ACC has released a press
release on the proposal.
|
|
| REGULATORY |
FDA,
Device Updates
Novartis
and the Food and Drug Administration (FDA) have notified health
care professionals that cases of pure red cell aplasia have
been reported in patients treated with mycophenolate mofetil
in combination with other immunosuppressive agents. MMF is
metabolized to mycophenolic acid (MPA), the active ingredient
in Myfortic and the active form of the drug. Read the complete
MedWatch
Safety summary.
Medtronic
Inc. recently warned physicians that about 6,300 of the company’s
Concerto and Virtuoso cardiac resynchronization therapy defibrillators
may not meet expected device longevity due to gradually increasing
current drain caused by low voltage capacitor degradation.
This issue may present in the affected devices as reaching
the recommended replacement time earlier than projected. This
issue does not compromise device functionality or affect therapy
delivery. Medtronic has received no reports of death or injury
attributed to this issue. The “Dear Doctor” letter
is available online.
|
|
| QUALITY |
Coverage
Available Online for ACC’s 2009 Legislative Conference
The
ACC held its 2009 Legislative Conference in Washington, D.C.,
on Sept. 13-15. The conference brought together over 350 ACC
members to learn more about current issues facing the cardiovascular
community, including the proposed 2010 Physician Fee Schedule,
health care reform, medical malpractice and state advocacy.
Attendees made hundreds of visits to offices on Capitol Hill,
reaching lawmakers and their staff on these very important
issues. For coverage of the conference, visit ACC’s
blog, The
Lewin Report, for more on key sessions, posts from attending
members, polls, videos and more.
|
|
|
|